P1053: NEUTROPHIL-TO-LYMPHOCYTE AND PLATELET-TO-LYMPHOCYTE RATIO AS NOVEL PROGNOSTIC BIOMARKES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

• Mirjana Cvetkovic,
• Jelena Ivanović,
• Isidora Arsenović,
• Mihailo Smiljanic,
• Magdalena Karasek,
• Olga Chyrko,
• Andrija Bogdanovic,
• Marta Sobas,
• Danijela Lekovic

Affiliations

Mirjana Cvetkovic

1 University Clinical Center Serbia, Clinic of Hematology, Beograd, Serbia

Jelena Ivanović

1 University Clinical Center Serbia, Clinic of Hematology, Beograd, Serbia

Isidora Arsenović

1 University Clinical Center Serbia, Clinic of Hematology, Beograd, Serbia

Mihailo Smiljanic

1 University Clinical Center Serbia, Clinic of Hematology, Beograd, Serbia

Magdalena Karasek

2 Medical University, Wrocław, Poland, Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wrocław, Poland

Olga Chyrko

2 Medical University, Wrocław, Poland, Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wrocław, Poland

Andrija Bogdanovic

1 University Clinical Center Serbia, Clinic of Hematology, Beograd, Serbia

Marta Sobas

2 Medical University, Wrocław, Poland, Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wrocław, Poland

Danijela Lekovic

1 University Clinical Center Serbia, Clinic of Hematology, Beograd, Serbia